Home Cart Sign in  
Chemical Structure| 78613-38-4 Chemical Structure| 78613-38-4

Structure of Amorolfine HCl
CAS No.: 78613-38-4

Chemical Structure| 78613-38-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Amorolfine HCl is a morpholine antifungal drug working by inhibiting Δ-sterol reductase.

Synonyms: Ro 14-4767/002; Amorolfine (hydrochloride); Ro 14-4767 HCl

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Amorolfine HCl

CAS No. :78613-38-4
Formula : C21H36ClNO
M.W : 353.97
SMILES Code : C[C@@H]1O[C@H](C)CN(CC(C)CC2=CC=C(C(C)(C)CC)C=C2)C1.[H]Cl
Synonyms :
Ro 14-4767/002; Amorolfine (hydrochloride); Ro 14-4767 HCl
MDL No. :MFCD00903738
InChI Key :XZKWIPVTHGWDCF-KUZYQSSXSA-N
Pubchem ID :54259

Safety of Amorolfine HCl

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H372-H410
Precautionary Statements:P501-P273-P260-P270-P264-P280-P391-P314-P337+P313-P305+P351+P338-P301+P312+P330
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02321098 Foot Dermatoses Phase 4 Completed - Iceland ... More >> Principal Investigator Reykjavik, Iceland Less <<
NCT03289871 Onychomycosis Not Applicable Completed - Tunisia ... More >> Hospital Habib Thameur Tunis, Tunisia Principal instruction military hospital Tunis, Tunisia Less <<
NCT03382717 Onychomycosis of Toenail Not Applicable Completed - Tunisia ... More >> Hospital Habib Thameur Tunis, Tunisia Principal instruction military hospital Tunis, Tunisia Less <<
NCT02321098 - Completed - -
NCT00938925 Onychomycosis Phase 1 Suspended(No funds) March 2017 Spain ... More >> School Health Sciences, University of Malaga Malaga, Málaga, Spain, 29009 Antonio Cuesta-vargas Malaga, Spain, 29009 Health Science School , University of Malaga Malaga, Spain, 29009 Less <<
NCT02679911 Foot Dermatoses Phase 4 Completed - Germany ... More >> Tübingen, Germany Less <<
NCT02549001 Onychomycosis Phase 3 Completed - Belgium ... More >> Polichem Investigative Site Multiple Locations, Belgium Bulgaria Polichem Investigative Site Multiple Locations, Bulgaria Czechia Polichem Investigative Site Multiple Locations, Czechia Germany Polichem Investigative Site Multiple Locations, Germany Greece Polichem Investigative Site Multiple Locations, Greece Hungary Polichem Investigative Site Multiple Locations, Hungary Iceland Polichem Investigative Site Various Cities In Iceland, Iceland Latvia Polichem Investigative Site Multiple Locations, Latvia Lithuania Polichem Investigative Site Multiple Locations, Lithuania Poland Polichem Investigative Site Multiple Locations, Poland Russian Federation Polichem Investigative Site Multiple Locations, Russian Federation Slovakia Polichem Investigative Site Multiple Locations, Slovakia Sweden Polichem Investigative Site Multiple Locations, Sweden Less <<
NCT02679911 - Completed - -
NCT02705664 Foot Dermatoses Phase 4 Completed - Iceland ... More >> Principal Investigator Reykjavik, Iceland Less <<
NCT01528813 Onychomycosis Phase 2 Unknown December 2013 Brazil ... More >> University Hospital of Brasilia Recruiting Brasilia, Federal District, Brazil, 70910-900 Contact: Orlando O Morais, M.D.    +55(61)99162339    orlando.unb@gmail.com    Principal Investigator: Orlando O Morais, M.D. Less <<
NCT00459537 Onychomycosis Phase 3 Completed - Finland ... More >> Novartis Investigative Site Various Cities, Finland France Novartis Investigative Site Various Cities, France Germany Novartis Investigative Site Various Cities, Germany Hungary Novartis Investigative Site Various Cities, Hungary Iceland Novartis Investigative Site Various Cities, Iceland Norway Novartis Investigative Site Various Cities, Norway Poland Novartis Investigative Site Various Cities, Poland Russian Federation Novartis Investigative Site Various Cities, Russian Federation Spain Novartis Investigative Site Various Cities, Spain Turkey Novartis Investigative Site Various Cities, Turkey Less <<
NCT03098342 Onychomycosis of Toenail Not Applicable Not yet recruiting January 31, 2019 Thailand ... More >> King Chulalongkorn Memorial Hospital Not yet recruiting Bangkok, Thailand, 10330 Contact: Nutthamon Bowornsathitchai, M.D.    66818239488    bee_o_bo@hotmail.com    Contact: Jaruwan Pemcharoen, B.Sc.    66823573912    photochulateam@gmail.com    Sub-Investigator: Anukorn Sriaram, B.Eng. Less <<
NCT00459537 - Completed - -
NCT01014637 Onychomycosis Phase 4 Unknown September 2011 France ... More >> Cabinet Médical Recruiting Argenteuil, France, 95100 Principal Investigator: Yves LE CORRE, MD          Cabinet Médical Recruiting Brest, France, 29200 Principal Investigator: Monique CHASSAIN LE LAY, MD          Cabinet Medical Recruiting Cholet, France, 49300 Principal Investigator: Jean-Michel DEBARRE, MD          Cabinet Médical Recruiting Martigues, France, 13500 Principal Investigator: Mireille RUER-MULLARD, MD          Cabinet Médical Recruiting Nice, France, 06000 Principal Investigator: Gilles ROSTAIN, MD          Cabinet Médical Recruiting Toulouse, France, 31000 Principal Investigator: Didier COUSTOU, MD          Hopital Purpan Not yet recruiting Toulouse, France Principal Investigator: Carle PAUL, Professor Less <<
NCT01851590 Onychomycosis Phase 4 Completed - Finland ... More >> Vääksyn Lääkärikeskus Vääksy, Finland, FI-17200 Less <<
NCT02812043 Non-dermatophyte Onychomycosis Phase 4 Recruiting August 2018 Thailand ... More >> Department of Dermatology Siriraj Hospital Recruiting Bangkoknoi, Bangkok, Thailand, 10700 Contact: Charussri Leeyaphan, MD    6624194333    charussrilee@gmail.com Less <<
NCT01929187 Onycomycosis Not Applicable Unknown July 2014 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Chiu-Nun Chen    +886+2-23562141    derm@ntuh.gov.tw    Principal Investigator: Jin-Bon Hong, MD Less <<
NCT01851590 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.83mL

0.57mL

0.28mL

14.13mL

2.83mL

1.41mL

28.25mL

5.65mL

2.83mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories